{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:53:38Z","timestamp":1790834018230,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T00:00:00Z","timestamp":1618012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T00:00:00Z","timestamp":1618012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004167","name":"Medicines for Malaria Venture","doi-asserted-by":"publisher","award":["OPP1111147"],"award-info":[{"award-number":["OPP1111147"]}],"id":[{"id":"10.13039\/501100004167","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Volunteer infection studies have become a standard model for evaluating drug efficacy against <jats:italic>Plasmodium<\/jats:italic> infections. Molecular techniques such as qPCR are used in these studies due to their ability to provide robust and accurate estimates of parasitaemia at increased sensitivity compared to microscopy. The validity and reliability of assays need to be ensured when used to evaluate the efficacy of candidate drugs in clinical trials.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A previously described 18S rRNA gene qPCR assay for quantifying <jats:italic>Plasmodium falciparum<\/jats:italic> in blood samples was evaluated. Assay performance characteristics including analytical sensitivity, reportable range, precision, accuracy and specificity were assessed using experimental data and data compiled from phase 1 volunteer infection studies conducted between 2013 and 2019. Guidelines for validation of laboratory-developed molecular assays were followed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The reportable range was 1.50 to 6.50 log<jats:sub>10<\/jats:sub> parasites\/mL with a limit of detection of 2.045 log<jats:sub>10<\/jats:sub> parasites\/mL of whole blood based on a parasite diluted standard series over this range. The assay was highly reproducible with minimal intra-assay (SD\u2009=\u20090.456 quantification cycle (C<jats:sub>q<\/jats:sub>) units [0.137 log<jats:sub>10<\/jats:sub> parasites\/mL] over 21 replicates) and inter-assay (SD\u2009=\u20090.604 C<jats:sub>q<\/jats:sub> units [0.182 log<jats:sub>10<\/jats:sub> parasites\/mL] over 786 qPCR runs) variability. Through an external quality assurance program, the QIMR assay was shown to generate accurate results (quantitative bias\u2009+\u20090.019 log<jats:sub>10<\/jats:sub> parasites\/mL against nominal values). Specificity was 100% after assessing 164 parasite-free human blood samples.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The 18S rRNA gene qPCR assay is specific and highly reproducible and can provide reliable and accurate parasite quantification. The assay is considered fit for use in evaluating drug efficacy in malaria clinical trials.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12936-021-03717-y","type":"journal-article","created":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T11:03:43Z","timestamp":1618052623000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Analytical validation of a real-time hydrolysis probe PCR assay for quantifying Plasmodium falciparum parasites in experimentally infected human adults"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2572-0760","authenticated-orcid":false,"given":"Claire Y. T.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma L.","family":"Ballard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuleima","family":"Pava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Marquart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Gaydon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean C.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Whiley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"O\u2019Rourke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,10]]},"reference":[{"key":"3717_CR1","volume-title":"World malaria report 2019","author":"WHO","year":"2019","unstructured":"WHO. World malaria report 2019. Geneva: World Health Organization; 2019."},{"key":"3717_CR2","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1473-3099(15)00487-9","volume":"16","author":"C Amaratunga","year":"2016","unstructured":"Amaratunga C, Lim P, Suon S, Sreng S, Mao S, Sopha C, et al. Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study. Lancet Infect Dis. 2016;16:357\u201365.","journal-title":"Lancet Infect Dis"},{"key":"3717_CR3","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411\u201323.","journal-title":"N Engl J Med"},{"key":"3717_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.pt.2015.11.010","volume":"32","author":"H Ranson","year":"2016","unstructured":"Ranson H, Lissenden N. Insecticide resistance in African Anopheles mosquitoes: a worsening situation that needs urgent action to maintain malaria control. Trends Parasitol. 2016;32:187\u201396.","journal-title":"Trends Parasitol"},{"key":"3717_CR5","doi-asserted-by":"publisher","first-page":"e01371","DOI":"10.1128\/AAC.01371-19","volume":"64","author":"JS McCarthy","year":"2019","unstructured":"McCarthy JS, Ruckle T, Elliott SL, Ballard E, Collins KA, Marquart L, et al. A single-dose combination study with the experimental antimalarials Artefenomel and DSM265 to determine safety and antimalarial activity against blood-stage Plasmodium falciparum in healthy volunteers. Antimicrob Agents Chemother. 2019;64:e01371-e1419.","journal-title":"Antimicrob Agents Chemother"},{"key":"3717_CR6","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1172\/JCI134923","volume":"130","author":"KA Collins","year":"2020","unstructured":"Collins KA, Wang CY, Adams M, Mitchell H, Robinson GJ, Rampton M, et al. A Plasmodium vivax experimental human infection model for evaluating the efficacy of interventions. J Clin Invest. 2020;130:2920\u20137.","journal-title":"J Clin Invest"},{"key":"3717_CR7","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/1475-2875-13-288","volume":"13","author":"E Kamau","year":"2014","unstructured":"Kamau E, Alemayehu S, Feghali KC, Komisar J, Regules J, Cowden J, et al. Measurement of parasitological data by quantitative real-time PCR from controlled human malaria infection trials at the Walter Reed Army Institute of Research. Malar J. 2014;13:288.","journal-title":"Malar J"},{"key":"3717_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nri2902","volume":"11","author":"RW Sauerwein","year":"2011","unstructured":"Sauerwein RW, Roestenberg M, Moorthy VS. Experimental human challenge infections can accelerate clinical malaria vaccine development. Nat Rev Immunol. 2011;11:57\u201364.","journal-title":"Nat Rev Immunol"},{"key":"3717_CR9","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/S1473-3099(18)30309-8","volume":"18","author":"A Llanos-Cuentas","year":"2018","unstructured":"Llanos-Cuentas A, Casapia M, Chuquiyauri R, Hinojosa JC, Kerr N, Rosario M, et al. Antimalarial activity of single-dose DSM265, a novel Plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study. Lancet Infect Dis. 2018;18:874\u201383.","journal-title":"Lancet Infect Dis"},{"key":"3717_CR10","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1186\/s12936-016-1434-z","volume":"15","author":"J Walk","year":"2016","unstructured":"Walk J, Schats R, Langenberg MC, Reuling IJ, Teelen K, Roestenberg M, et al. Diagnosis and treatment based on quantitative PCR after controlled human malaria infection. Malar J. 2016;15:398.","journal-title":"Malar J"},{"key":"3717_CR11","doi-asserted-by":"publisher","first-page":"e109654","DOI":"10.1371\/journal.pone.0109654","volume":"9","author":"AK Talley","year":"2014","unstructured":"Talley AK, Healy SA, Finney OC, Murphy SC, Kublin J, Salas CJ, et al. Safety and comparability of controlled human Plasmodium falciparum infection by mosquito bite in malaria-na\u00efve subjects at a new facility for sporozoite challenge. PLoS ONE. 2014;9:e109654.","journal-title":"PLoS ONE"},{"key":"3717_CR12","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1146\/annurev-pharmtox-010715-103429","volume":"58","author":"KA Andrews","year":"2018","unstructured":"Andrews KA, Wesche D, McCarthy J, Mohrle JJ, Tarning J, Phillips L, et al. Model-informed drug development for malaria therapeutics. Annu Rev Pharmacol Toxicol. 2018;58:567\u201382.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"3717_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12936-015-0628-0","volume":"14","author":"B Mordmuller","year":"2015","unstructured":"Mordmuller B, Supan C, Sim KL, Gomez-Perez GP, Ospina Salazar CL, Held J, et al. Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres. Malar J. 2015;14:117.","journal-title":"Malar J"},{"key":"3717_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3347\/kjp.2009.47.2.93","volume":"47","author":"N Tangpukdee","year":"2009","unstructured":"Tangpukdee N, Duangdee C, Wilairatana P, Krudsood S. Malaria diagnosis: a brief review. Korean J Parasitol. 2009;47:93\u2013102.","journal-title":"Korean J Parasitol"},{"key":"3717_CR15","doi-asserted-by":"publisher","first-page":"7065","DOI":"10.1016\/j.vaccine.2017.10.093","volume":"35","author":"M Roestenberg","year":"2017","unstructured":"Roestenberg M, Mordmuller B, Ockenhouse C, Mo A, Yazdanbakhsh M, Kremsner PG. The frontline of controlled human malaria infections: a report from the controlled human infection models Workshop in Leiden University Medical Centre 5 May 2016. Vaccine. 2017;35:7065\u20139.","journal-title":"Vaccine"},{"key":"3717_CR16","doi-asserted-by":"publisher","first-page":"824","DOI":"10.4269\/ajtmh.12-0675","volume":"89","author":"SC Murphy","year":"2013","unstructured":"Murphy SC, Shott JP, Parikh S, Etter P, Prescott WR, Stewart VA. Malaria diagnostics in clinical trials. Am J Trop Med Hyg. 2013;89:824\u201339.","journal-title":"Am J Trop Med Hyg"},{"key":"3717_CR17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.4269\/ajtmh.2012.10-0658","volume":"86","author":"SC Murphy","year":"2012","unstructured":"Murphy SC, Prentice JL, Williamson K, Wallis CK, Fang FC, Fried M, et al. Real-time quantitative reverse transcription PCR for monitoring of blood-stage Plasmodium falciparum infections in malaria human challenge trials. Am J Trop Med Hyg. 2012;86:383\u201394.","journal-title":"Am J Trop Med Hyg"},{"key":"3717_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/1475-2875-5-121","volume":"5","author":"RE Coleman","year":"2006","unstructured":"Coleman RE, Sattabongkot J, Promstaporm S, Maneechai N, Tippayachai B, Kengluecha A, et al. Comparison of PCR and microscopy for the detection of asymptomatic malaria in a Plasmodium falciparum\/vivax endemic area in Thailand. Malar J. 2006;5:121.","journal-title":"Malar J"},{"key":"3717_CR19","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/nrmicro3364","volume":"12","author":"T Bousema","year":"2014","unstructured":"Bousema T, Okell L, Felger I, Drakeley C. Asymptomatic malaria infections: detectability, transmissibility and public health relevance. Nat Rev Microbiol. 2014;12:833\u201340.","journal-title":"Nat Rev Microbiol"},{"key":"3717_CR20","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1172\/JCI98012","volume":"128","author":"KA Collins","year":"2018","unstructured":"Collins KA, Wang CY, Adams M, Mitchell H, Rampton M, Elliott S, et al. A controlled human malaria infection model enabling evaluation of transmission-blocking interventions. J Clin Invest. 2018;128:1551\u201362.","journal-title":"J Clin Invest"},{"key":"3717_CR21","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/infdis\/jix613","volume":"217","author":"SC Murphy","year":"2018","unstructured":"Murphy SC, Duke ER, Shipman KJ, Jensen RL, Fong Y, Ferguson S, et al. A randomized trial evaluating the prophylactic activity of DSM265 against preerythrocytic Plasmodium falciparum infection during controlled human malarial infection by mosquito bites and direct venous inoculation. J Infect Dis. 2018;217:693\u2013702.","journal-title":"J Infect Dis"},{"key":"3717_CR22","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.4269\/ajtmh.19-0094","volume":"100","author":"AM Seilie","year":"2019","unstructured":"Seilie AM, Chang M, Hanron AE, Billman ZP, Stone BC, Zhou K, et al. Beyond blood smears: qualification of Plasmodium 18S rRNA as a biomarker for controlled human malaria infections. Am J Trop Med Hyg. 2019;100:1466\u201376.","journal-title":"Am J Trop Med Hyg"},{"key":"3717_CR23","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1128\/AAC.04942-14","volume":"59","author":"L Marquart","year":"2015","unstructured":"Marquart L, Baker M, O\u2019Rourke P, McCarthy JS. Evaluating the pharmacodynamic effect of antimalarial drugs in clinical trials by quantitative PCR. Antimicrob Agents Chemother. 2015;59:4249\u201359.","journal-title":"Antimicrob Agents Chemother"},{"key":"3717_CR24","doi-asserted-by":"publisher","first-page":"e21914","DOI":"10.1371\/journal.pone.0021914","volume":"6","author":"JS McCarthy","year":"2011","unstructured":"McCarthy JS, Sekuloski S, Griffin PM, Elliott S, Douglas N, Peatey C, et al. A pilot randomised trial of induced blood-stage Plasmodium falciparum infections in healthy volunteers for testing efficacy of new antimalarial drugs. PLoS ONE. 2011;6:e21914.","journal-title":"PLoS ONE"},{"key":"3717_CR25","doi-asserted-by":"publisher","first-page":"196","DOI":"10.4269\/ajtmh.2004.71.2.0700196","volume":"71","author":"CC Hermsen","year":"2004","unstructured":"Hermsen CC, de Vlas SJ, van Gemert GJ, Telgt DS, Verhage DF, Sauerwein RW. Testing vaccines in human experimental malaria: statistical analysis of parasitemia measured by a quantitative real-time polymerase chain reaction. Am J Trop Med Hyg. 2004;71:196\u2013201.","journal-title":"Am J Trop Med Hyg"},{"key":"3717_CR26","doi-asserted-by":"publisher","first-page":"5792","DOI":"10.1128\/AAC.00287-13","volume":"57","author":"NJ White","year":"2013","unstructured":"White NJ. Pharmacokinetic and pharmacodynamic considerations in antimalarial dose optimization. Antimicrob Agents Chemother. 2013;57:5792\u2013807.","journal-title":"Antimicrob Agents Chemother"},{"key":"3717_CR27","doi-asserted-by":"publisher","first-page":"e01940","DOI":"10.1128\/AAC.01940-16","volume":"61","author":"TT Hien","year":"2017","unstructured":"Hien TT, White NJ, Thuy-Nhien NT, Hoa NT, Thuan PD, Tarning J, et al. Estimation of the in vivo MIC of Cipargamin in uncomplicated Plasmodium falciparum malaria. Antimicrob Agents Chemother. 2017;61:e01940-e2016.","journal-title":"Antimicrob Agents Chemother"},{"key":"3717_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1475-2875-10-48","volume":"10","author":"RJ Rockett","year":"2011","unstructured":"Rockett RJ, Tozer SJ, Peatey C, Bialasiewicz S, Whiley DM, Nissen MD, et al. A real-time, quantitative PCR method using hydrolysis probes for the monitoring of Plasmodium falciparum load in experimentally infected human volunteers. Malar J. 2011;10:48.","journal-title":"Malar J"},{"key":"3717_CR29","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1128\/CMR.00074-09","volume":"23","author":"EM Burd","year":"2010","unstructured":"Burd EM. Validation of laboratory-developed molecular assays for infectious diseases. Clin Microbiol Rev. 2010;23:550\u201376.","journal-title":"Clin Microbiol Rev"},{"key":"3717_CR30","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","volume":"55","author":"SA Bustin","year":"2009","unstructured":"Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009;55:611\u201322.","journal-title":"Clin Chem"},{"key":"3717_CR31","unstructured":"CLSI. Protocols for determination for limits of detection and limits of quantitation. Approved guideline. Wayne, PA; 2004. Contract No. EP17-A."},{"key":"3717_CR32","unstructured":"CLSI. Defining, establishing and verifying reference intervals in the clinical laboratory. Approved guideline. Wayne, PA; 2008. Contract No. C28-A3."},{"key":"3717_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.molbiopara.2008.10.004","volume":"163","author":"MW Dixon","year":"2009","unstructured":"Dixon MW, Peatey CL, Gardiner DL, Trenholme KR. A green fluorescent protein-based assay for determining gametocyte production in Plasmodium falciparum. Mol Biochem Parasitol. 2009;163:123\u20136.","journal-title":"Mol Biochem Parasitol"},{"key":"3717_CR34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/978-1-61779-439-1_2","volume":"820","author":"M Forlenza","year":"2012","unstructured":"Forlenza M, Kaiser T, Savelkoul HF, Wiegertjes GF. The use of real-time quantitative PCR for the analysis of cytokine mRNA levels. Methods Mol Biol. 2012;820:7\u201323.","journal-title":"Methods Mol Biol"},{"key":"3717_CR35","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/clinchem\/27.3.493","volume":"27","author":"JO Westgard","year":"1981","unstructured":"Westgard JO, Barry PL, Hunt MR, Groth T. A multi-rule Shewhart chart for quality control in clinical chemistry. Clin Chem. 1981;27:493\u2013501.","journal-title":"Clin Chem"},{"key":"3717_CR36","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/sti.2008.032607","volume":"85","author":"S Bialasiewicz","year":"2009","unstructured":"Bialasiewicz S, Whiley DM, Buhrer-Skinner M, Bautista C, Barker K, Aitken S, et al. A novel gel-based method for self-collection and ambient temperature postal transport of urine for PCR detection of Chlamydia trachomatis. Sex Transm Infect. 2009;85:102\u20135.","journal-title":"Sex Transm Infect"},{"key":"3717_CR37","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s12936-018-2382-6","volume":"17","author":"CYT Wang","year":"2018","unstructured":"Wang CYT, McCarthy JS, Stone WJ, Bousema T, Collins KA, Bialasiewicz S. Assessing Plasmodium falciparum transmission in mosquito-feeding assays using quantitative PCR. Malar J. 2018;17:249.","journal-title":"Malar J"},{"key":"3717_CR38","doi-asserted-by":"publisher","first-page":"e97398","DOI":"10.1371\/journal.pone.0097398","volume":"9","author":"SC Murphy","year":"2014","unstructured":"Murphy SC, Hermsen CC, Douglas AD, Edwards NJ, Petersen I, Fahle GA, et al. External quality assurance of malaria nucleic acid testing for clinical trials and eradication surveillance. PLoS ONE. 2014;9:e97398.","journal-title":"PLoS ONE"},{"key":"3717_CR39","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1111\/j.1365-2672.2012.05384.x","volume":"113","author":"C Schrader","year":"2012","unstructured":"Schrader C, Schielke A, Ellerbroek L, Johne R. PCR inhibitors\u2014occurrence, properties and removal. J Appl Microbiol. 2012;113:1014\u201326.","journal-title":"J Appl Microbiol"},{"key":"3717_CR40","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1128\/JCM.39.2.485-493.2001","volume":"39","author":"WA Al-Soud","year":"2001","unstructured":"Al-Soud WA, Radstrom P. Purification and characterization of PCR-inhibitory components in blood cells. J Clin Microbiol. 2001;39:485\u201393.","journal-title":"J Clin Microbiol"},{"key":"3717_CR41","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1128\/aem.63.10.3741-3751.1997","volume":"63","author":"IG Wilson","year":"1997","unstructured":"Wilson IG. Inhibition and facilitation of nucleic acid amplification. Appl Environ Microbiol. 1997;63:3741\u201351.","journal-title":"Appl Environ Microbiol"},{"key":"3717_CR42","first-page":"963","volume":"221","author":"LF Wockner","year":"2020","unstructured":"Wockner LF, Hoffmann I, Webb L, Mordmuller B, Murphy SC, Kublin JG, et al. Growth Rate of Plasmodium falciparum: analysis of parasite growth data from malaria volunteer infection studies. J Infect Dis. 2020;221:963\u201372.","journal-title":"J Infect Dis"},{"key":"3717_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bdq.2017.04.001","volume":"12","author":"A Forootan","year":"2017","unstructured":"Forootan A, Sjoback R, Bjorkman J, Sjogreen B, Linz L, Kubista M. Methods to determine limit of detection and limit of quantification in quantitative real-time PCR (qPCR). Biomol Detect Quantif. 2017;12:1\u20136.","journal-title":"Biomol Detect Quantif"},{"key":"3717_CR44","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1093\/jac\/dkw174","volume":"71","author":"JS McCarthy","year":"2016","unstructured":"McCarthy JS, Baker M, O\u2019Rourke P, Marquart L, Griffin P, Hooft van Huijsduijnen R, et al. Efficacy of OZ439 (artefenomel) against early Plasmodium falciparum blood-stage malaria infection in healthy volunteers. J Antimicrob Chemother. 2016;71:2620\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"3717_CR45","doi-asserted-by":"publisher","first-page":"188","DOI":"10.4269\/ajtmh.16-0893","volume":"97","author":"FG Tadesse","year":"2017","unstructured":"Tadesse FG, Lanke K, Nebie I, Schildkraut JA, Goncalves BP, Tiono AB, et al. Molecular markers for sensitive detection of Plasmodium falciparum asexual stage parasites and their application in a malaria clinical trial. Am J Trop Med Hyg. 2017;97:188\u201398.","journal-title":"Am J Trop Med Hyg"},{"key":"3717_CR46","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3325\/cmj.2009.50.207","volume":"50","author":"B Budowle","year":"2009","unstructured":"Budowle B, Eisenberg AJ, van Daal A. Validity of low copy number typing and applications to forensic science. Croat Med J. 2009;50:207\u201317.","journal-title":"Croat Med J"},{"key":"3717_CR47","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1128\/JCM.01057-14","volume":"52","author":"M Imwong","year":"2014","unstructured":"Imwong M, Hanchana S, Malleret B, Renia L, Day NP, Dondorp A, et al. High-throughput ultrasensitive molecular techniques for quantifying low-density malaria parasitemias. J Clin Microbiol. 2014;52:3303\u20139.","journal-title":"J Clin Microbiol"},{"key":"3717_CR48","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1186\/s12936-015-1038-z","volume":"14","author":"M Adams","year":"2015","unstructured":"Adams M, Joshi SN, Mbambo G, Mu AZ, Roemmich SM, Shrestha B, et al. An ultrasensitive reverse transcription polymerase chain reaction assay to detect asymptomatic low-density Plasmodium falciparum and Plasmodium vivax infections in small volume blood samples. Malar J. 2015;14:520.","journal-title":"Malar J"},{"key":"3717_CR49","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s41182-019-0176-3","volume":"47","author":"E Ballard","year":"2019","unstructured":"Ballard E, Wang CYT, Hien TT, Tong NT, Marquart L, Pava Z, et al. A validation study of microscopy versus quantitative PCR for measuring Plasmodium falciparum parasitemia. Trop Med Health. 2019;47:49.","journal-title":"Trop Med Health"},{"key":"3717_CR50","doi-asserted-by":"publisher","first-page":"39183","DOI":"10.1038\/srep39183","volume":"6","author":"C Koepfli","year":"2016","unstructured":"Koepfli C, Nguitragool W, Hofmann NE, Robinson LJ, Ome-Kaius M, Sattabongkot J, et al. Sensitive and accurate quantification of human malaria parasites using droplet digital PCR (ddPCR). Sci Rep. 2016;6:39183.","journal-title":"Sci Rep"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-021-03717-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-021-03717-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-021-03717-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T07:05:59Z","timestamp":1675148759000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-021-03717-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,10]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["3717"],"URL":"https:\/\/doi.org\/10.1186\/s12936-021-03717-y","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,10]]},"assertion":[{"value":"14 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Blood samples were collected during the course of VIS, which were all approved by the QIMR Human Research Ethics Committee. Details of the studies and ethical approval have been published ([], Additional file : Table S2).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"181"}}